Evidence map›Paper›PMID 26089646›Full record

ArticleDrug design, development and therapy2015

Oxidant/antioxidant status, paraoxonase activity, and lipid profile in plasma of ovariectomized rats under the influence of estrogen, estrogen combined with progesterone, and genistein.

Elif Agacayak, Serdar Basaranoglu, Senem Yaman Tunc, Mehmet Sait Icen, Fatih Mehmet Findik, Ibrahim Kaplan, Osman Evliyaoglu, Talip Gul

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pharmacological Effects of Genistein on Cardiovascular Diseases.Evidence-based complementary and alternative medicine : eCAM · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Elif AgacayakDepartment of Obstetrics and Gynecology, Dicle University School of Medicine, Diyarbakir, Turkey.
Serdar BasaranogluDepartment of Obstetrics and Gynecology, Idil State Hospital, Sirnak, Turkey.
Senem Yaman TuncDepartment of Obstetrics and Gynecology, Dicle University School of Medicine, Diyarbakir, Turkey.
Mehmet Sait IcenDepartment of Obstetrics and Gynecology, Dicle University School of Medicine, Diyarbakir, Turkey.
Fatih Mehmet FindikDepartment of Obstetrics and Gynecology, Dicle University School of Medicine, Diyarbakir, Turkey.
Ibrahim KaplanDepartment of Biochemistry, Dicle University School of Medicine, Diyarbakir, Turkey.
Osman EvliyaogluDepartment of Biochemistry, Dicle University School of Medicine, Diyarbakir, Turkey.
Talip GulDepartment of Obstetrics and Gynecology, Dicle University School of Medicine, Diyarbakir, Turkey.
Dicle University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study was to investigate whether estradiol (E2), E2 combined with progesterone (Prog) (E2/Prog), and genistein (Gen) treatment had antioxidative and anti-hyperlipidemic effects in the plasma of ovariectomized (OVX) rats. MATERIALS AND

methodsAdult female Sprague-Dawley rats were divided into five groups. Rats in all groups, except for those in a sham group, underwent bilateral ovariectomy under general anesthesia. The groups were as follows: sham group; control OVX group; group treated with estrogen (0.014 mg/kg 17-β E2); group treated with a combination of E2 and Prog (0.014 mg/kg 17-β E2 plus 0.028 mg/kg drospirenone), and group treated with Gen (10 mg/kg/day). Plasma of rats of each treatment group was analyzed to determine the total antioxidant status, total oxidant status, paraoxonase activity, lipid profile, high-density lipoprotein (HDL-chol), low-density lipoprotein (LDL-chol), total cholesterol (Total-C), triacylglycerols, lipoprotein (a), and oxidative stress index.

resultsPlasma Total-C levels and body weight increased in all the OVX groups compared with the sham group (P<0.005). The group treated with E2 had significantly elevated total oxidant status, oxidative stress index, LDL-chol, and Total-C compared with the control group (P<0.005). Gen treatment might lead to lower LDL-chol and Total-C levels compared with E2 treatment.

conclusionsGen treatment might be preferred to E2 treatment for treatment of menopausal symptoms in patients at risk for cardiovascular diseases. However, considering the small sample size of this study, larger studies are needed in this area.

Indexed as

OvariectomyAnimalsAntioxidantsAryldialkylphosphataseBody WeightEstradiolEstrogen Replacement TherapyEstrogensFemaleGenisteinLipidsOxidantsProgesteroneProgestinsRatsRats, Sprague-DawleyAntioxidantsAryldialkylphosphataseEstradiolEstrogensGenisteinLipidsOxidantsProgesteroneProgestinscardiovascular diseasesgenisteinmenopause

Identifiers

PMID26089646
PMCPMC4468937
OpenAlexW1679213437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.